(VIANEWS) – Jiayin Group (JFIN), Alkermes plc (ALKS), Intercontinental Exchange (ICE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Jiayin Group (JFIN)
136.4% sales growth and 120.58% return on equity
Jiayin Group Inc. operates as an online individual finance platform that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers. The company was founded in 2011 and is based in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Jiayin Group has a trailing twelve months EPS of $3.44.
PE Ratio
Jiayin Group has a trailing twelve months price to earnings ratio of 1.44. Meaning, the purchaser of the share is investing $1.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 120.58%.
Moving Average
Jiayin Group’s value is way below its 50-day moving average of $5.55 and higher than its 200-day moving average of $4.54.
Yearly Top and Bottom Value
Jiayin Group’s stock is valued at $4.97 at 16:22 EST, way under its 52-week high of $8.19 and way above its 52-week low of $1.86.
Sales Growth
Jiayin Group’s sales growth is negative 3.5% for the present quarter and 136.4% for the next.
2. Alkermes plc (ALKS)
72.5% sales growth and 8.72% return on equity
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an extended-release intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia; and VUMERITY (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI (olanzapine/samidorphan), an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International; a license agreement with Acorda Therapeutics, Inc.; and a license and collaboration agreement with Biogen Swiss Manufacturing GmbH. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Alkermes plc has a trailing twelve months EPS of $0.55.
PE Ratio
Alkermes plc has a trailing twelve months price to earnings ratio of 50.42. Meaning, the purchaser of the share is investing $50.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.72%.
Sales Growth
Alkermes plc’s sales growth is 33.5% for the ongoing quarter and 72.5% for the next.
Moving Average
Alkermes plc’s value is under its 50-day moving average of $28.69 and below its 200-day moving average of $28.86.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 2050% and 257.1%, respectively.
3. Intercontinental Exchange (ICE)
22.6% sales growth and 7.5% return on equity
Intercontinental Exchange, Inc., together with its subsidiaries, engages in the provision of market infrastructure, data services, and technology solutions for financial institutions, corporations, and government entities in the United States, the United Kingdom, the European Union, Singapore, India, Abu Dhabi, Israel, and Canada. It operates through three segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The company operates regulated marketplaces for listing, trading, and clearing an array of derivatives contracts and financial securities, such as commodities, interest rates, foreign exchange, and equities, as well as corporate and exchange-traded funds; and trading venues, including regulated exchanges and clearing houses. It also offers energy, agricultural and metals, and financial futures and options; and cash equities and equity options, and over-the-counter and other markets, as well as listings and data and connectivity services. In addition, the company provides fixed income data and analytic, fixed income execution, CDS clearing, and other multi-asset class data and network services. Further, it offers proprietary and comprehensive mortgage origination platform, which serves residential mortgage loans; closing solutions that provides customers connectivity to the mortgage supply chain and facilitates the secure exchange of information; data and analytics services; and Data as a Service for lenders to access data and origination information. Intercontinental Exchange, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Intercontinental Exchange has a trailing twelve months EPS of $3.01.
PE Ratio
Intercontinental Exchange has a trailing twelve months price to earnings ratio of 36.24. Meaning, the purchaser of the share is investing $36.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.5%.
Yearly Top and Bottom Value
Intercontinental Exchange’s stock is valued at $109.08 at 16:22 EST, under its 52-week high of $118.79 and way higher than its 52-week low of $92.26.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 7.36B for the twelve trailing months.
Volume
Today’s last reported volume for Intercontinental Exchange is 950706 which is 60.58% below its average volume of 2412150.
4. Iron Mountain Incorporated (IRM)
14.2% sales growth and 60.86% return on equity
Iron Mountain Incorporated (NYSE: IRM), founded in 1951, is the global leader for storage and information management services. Trusted by more than 225,000 organizations around the world, and with a real estate network of more than 90 million square feet across more than 1,480 facilities in approximately 50 countries, Iron Mountain stores and protects billions of valued assets, including critical business information, highly sensitive data, and cultural and historical artifacts. Providing solutions that include secure records storage, information management, digital transformation, secure destruction, as well as data centers, cloud services and art storage and logistics, Iron Mountain helps customers lower cost and risk, comply with regulations, recover from disaster, and enable a more digital way of working.
Earnings Per Share
As for profitability, Iron Mountain Incorporated has a trailing twelve months EPS of $1.29.
PE Ratio
Iron Mountain Incorporated has a trailing twelve months price to earnings ratio of 46.26. Meaning, the purchaser of the share is investing $46.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.86%.
5. Meta Platforms (META)
14.1% sales growth and 17.36% return on equity
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $8.57.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 36.23. Meaning, the purchaser of the share is investing $36.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.36%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Meta Platforms’s EBITDA is 60.64.
Moving Average
Meta Platforms’s value is above its 50-day moving average of $302.84 and way above its 200-day moving average of $246.56.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11%, now sitting on 120.52B for the twelve trailing months.
Previous days news about Meta Platforms(META)
- According to Zacks on Friday, 20 October, "When you look at individual holdings, Nvidia Corp (NVDA Quick QuoteNVDA – Free Report) accounts for about 6.23% of the fund’s total assets, followed by Meta Platforms Inc Class A (META Quick QuoteMETA – Free Report) and Visa Inc Class A (V Quick QuoteV – Free Report) ."
- According to Zacks on Friday, 20 October, "Two mega-cap names on the docket include Meta Platforms (META Quick QuoteMETA – Free Report) and Alphabet (GOOGL Quick QuoteGOOGL – Free Report) . "
6. Opera Limited (OPRA)
11.1% sales growth and 6.9% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. It operates in two segments, Browser and News, and Other. The company offers mobile browser products, such as Opera Mini, Opera for Android and iOS, Opera GX Mobile, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Apex Football; Opera VPN Pro; and Opera News, an AI-powered personalized news discovery and aggregation service. It also provides Opera Crypto Browser for PCs and mobile; browser-based cashback rewards; owns GameMaker Studio, a 2D gaming development platform; and GXC, a gaming portal. In addition, the company operates Opera Ads, an online advertising platform. It operates in Nigeria, Ireland, France, Germany, Spain, England, South Africa, Kenya, and internationally. The company was founded in 1995 and is headquartered in Oslo, Norway. Opera Limited is a subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.6.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 17.93. Meaning, the purchaser of the share is investing $17.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.
Yearly Top and Bottom Value
Opera Limited’s stock is valued at $10.76 at 16:22 EST, way under its 52-week high of $28.58 and way above its 52-week low of $3.92.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Opera Limited’s EBITDA is 94.3.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 50% and a drop 40.7% for the next.
7. Brookline Bancorp (BRKL)
6.9% sales growth and 8.38% return on equity
Brookline Bancorp, Inc. operates as a bank holding company for the Brookline Bank that provide commercial, business, and retail banking services to corporate, municipal, and retail customers in the United States. Its deposit products include demand checking, NOW, money market, and savings accounts. The company's loan portfolio primarily comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; loans and leases used to finance equipment for small businesses; financing for construction and development projects; and home equity and other consumer loans. It also provides term loans, letters of credit, foreign exchange, cash management, investment advisory, and online and mobile banking services, as well as invests in debt and equity securities. As of December 31, 2021, the company operated 50 full-service banking offices in greater Boston, Massachusetts, and greater Providence, Rhode Island. Brookline Bancorp, Inc. was founded in 1871 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Brookline Bancorp has a trailing twelve months EPS of $1.11.
PE Ratio
Brookline Bancorp has a trailing twelve months price to earnings ratio of 7.97. Meaning, the purchaser of the share is investing $7.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.38%.
Moving Average
Brookline Bancorp’s worth is below its 50-day moving average of $9.42 and way under its 200-day moving average of $10.43.
Volume
Today’s last reported volume for Brookline Bancorp is 312625 which is 32% below its average volume of 459781.
Yearly Top and Bottom Value
Brookline Bancorp’s stock is valued at $8.85 at 16:22 EST, way below its 52-week high of $15.50 and way above its 52-week low of $7.00.
